English
中文 (香港)
About AFCR
Mission
Our Team
Council Members and Advisors
Reports
Our Partners
FAQs
Contact Us
Research Program
Basic Research
Translational Research
Clinical Research
BRACE Award
Global Summit
Women in Cancer Research
Young Investigator Award
Cancer Facts
AFCR News
Ways to Give
Donate Now
Donate Monthly
Gifts In Memory
Gifts in Honor
Contact Us
Blog
Long term benefits of immunotherapy emerging for some patients, though key questions remain
Anne Li April…...
Read more
9 burning questions about CRISPR genome editing answered
Anne Li April…...
Read more
Breast cancer drug approved for use in Scotland, though concerns remain about patients getting the drug across the UK
Anne Li April…...
Read more
Immunotherapy drug too costly for head and neck cancer
Anne Li April…...
Read more
Study suggests why an immunotherapy drug works in some melanoma patients but not in others
Anne Li April…...
Read more
Blocking growth of tumour blood vessels could boost immunotherapy
Anne Li April…...
Read more
Blood tests, microbes, immunotherapy and more: AACR 2017’s hottest topics
Anne Li April…...
Read more
Cancer living outside the body, unravelling a cellular mystery and targeting ‘sleeping’ cancer cells: our latest cutting-edge science projects
Anne Li April…...
Read more
News digest – immunotherapies showing promise, breast cancer drug approved for Scotland, childhood cancer rates, and… killer sofas?
Anne Li April…...
Read more
Targeting cancer spread: keeping breast tumours under LOX and key
Anne Li April…...
Read more
73
74
75
76
77
78
79
80
81
82
83
84
85
Sign Up for AFCR’s Newsletter
Notice: JavaScript is required for this content.
×
Your ticket for the: Targeting cancer spread: keeping breast tumours under LOX and key
Title
Targeting cancer spread: keeping breast tumours under LOX and key
USD
